Relative importance of the operating conditions involved in the formation of nanoparticles of ampicillin by supercritical antisolvent precipitation

Industrial and Engineering Chemistry Research

Volumn 46, Issue 1, 2007, Pages 114-123

  Tenorio, Alvaro ^a   Gordillo, Maria D ^a   Pereyra, Clara M ^a   Martínez De La Ossa, Enrique J ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONCENTRATION (PROCESS); PARTICLE SIZE ANALYSIS; PRECIPITATION (CHEMICAL); SOLVENTS; SUPERCRITICAL FLUIDS;

DESIGN OF EXPERIMENT (DOE); SUPERCRITICAL ANTISOLVENT PRECIPITATION;

NANOSTRUCTURED MATERIALS;

CONCENTRATION (PROCESS); NANOSTRUCTURED MATERIALS; PARTICLE SIZE ANALYSIS; PRECIPITATION (CHEMICAL); SOLVENTS; SUPERCRITICAL FLUIDS;

EID: 33847081696     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie0606441     Document Type: Article

References (55)

1. 2 antisolvent with enhanced mass transfer. Int. J. Pharm. 2001, 228, 19-31.
2. Steckel, H.; Thies, J.; Muller, B. W. Micronizing of steroids for pulmonary delivery by supercritical carbon dioxide. Int. J. Pharm. 1997, 152, 99-110.
3. Steckel, H.; Muller, B. W. Metered-dose inhaler formulation of fluticasone-17-propionate micronized with supercritical carbon dioxide using the alternative propellant HFA-227. Int. J. Pharm. 1998, 173, 25-33.
4. Reverchon, E.; Della Porta, G. Production of antibiotic micro- and nano-particles by supercritical antisolvent precipitation. Powder Technol. 1999, 106, 23-29.
5. Reverchon, E.; Della Porta, G.; Falivene, M. G. Process parameters and morphology in amoxicillin micro and submicro particle generation by supercritical antisolvent precipitation. J. Supercrit. Fluids 2000, 17, 239-248.
6. 2 as antisolvent with enhanced mass transfer. Ind. Eng. Chem. Res. 2001, 40, 3530-3539.
7. Moshashaee, S.; Bisrat, M.; Forbes, R. T.; Nyqvist, H.; York, P. Supercritical fluid processing of proteins I: Lysozyme precipitation from organic solution. J. Pharm. Sci. 2000, 11, 239-245.
8. 2. J. Supercrit. Fluids 2001, 21, 257-271.
9. Rehman, M.; Shekunov, B. Y.; York, P.; Colthorpe, P. Solubility and precipitation of nicotinic acid in supercritical carbon dioxide. J. Pharm. Sci. 2001, 90, 1570-1582.
10. Reverchon, E.; Della Porta, G.; Pallado, P. Supercritical antisolvent precipitation of salbutamol microparticles. Powder Technol. 2001, 114, 17-22.
11. Reverchon, E.; De Marco, I.; Della Porta, G. Rifampicin microparticles production by supercritical antisolvent precipitation. Int. J. Pharm. 2002, 243, 83-91.
12. Reverchon, E. Supercritical-assisted atomization to produce micro- and/or nanoparticles of controlled size and distribution. Ind. Eng. Chem. Res. 2002, 41, 2405-2411.
13. Snavely, W. K.; Subramaniam, B.; Rajewski, R. A.; Defelippis, M. R. Micronization of insulin from halogenated alcohol solution using supercritical carbon dioxide as an antisolvent. J. Pharm. Sci. 2002, 91, 2026-2039.
14. Tu, L. S.; Dehghani, F.; Foster, N. R. Micronisation and micro encapsulation of pharmaceuticals using a carbon dioxide antisolvent. Powder Technol. 2002, 126, 134-149.
15. Velaga, S. P.; Ghaderi, R.; Carlfors, J. Preparation and characterisation of hydrocortisone particles using a supercritical fluids extraction process. Int. J. Pharm. 2002, 231, 155-166.
16. Reverchon, E.; Della Porta, G.; Spada, A. Ampicillin micronization by supercritical assisted atomization. J. Pharm. Pharmacol. 2003, 55, 1465-1471.
17. Reverchon, E.; Della Porta, G. Micronization of antibiotics by supercritical assisted atomization. J. Supercrit. Fluids 2003, 26, 243-252.
18. Reverchon, E.; Della Porta, G. Terbutaline microparticles suitable for aerosol delivery produced by supercritical assisted atomization. Int. J. Pharm. 2003, 258, 1-9.
19. 2. Cryst. Growth Des. 2003, 3, 603-610.
20. Yeo, S.-D.; Kim, M.-S.; Lee, J.-C. Recrystallization of sulfathiazole and chlorpropamide using the supercritical fluid antisolvent process. J. Supercrit. Fluids 2003, 25, 143-154.
21. Rehman, M.; Shekunov, B. Y.; York, P.; Lechuga-Ballesteros, D.; Miller, D. P.; Tan, T.; Colthorpe, P. Optimisation of powders for pulmonary delivery using supercritical fluid technology. Eur. J. Pharm. Biopharm. 2004, 22, 1-17.
22. Reverchon, E.; De Marco, L. Supercritical antisolvent micronization of Cefonicid: thermodynamic interpretation of results. J. Supercrit. Fluids 2004, 31, 207-215.
23. Reverchon, E.; Spada, A. Erythromycin micro-particles produced by supercritical fluid atomization. Powder Technol. 2004, 141, 100-108.
24. Schiavone, H.; Palakodaty, S.; Tzannis, S. T.; Clark, A.; York, P. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers. Int. J. Pharm. 2004, 281, 55-66.
25. Steckel, H.; Wehle, S. A novel formulation technique for metered dose inhaler (MDI) suspensions. Int. J. Pharm. 2004, 284, 75-82.
26. Steckel, H.; Pichert, L.; Müller, B. W. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery. Eur. J. Pharm. Biopharm. 2004, 57, 507-512.
27. Velaga, S. P.; Bergh, S.; Carlfors, J. Stability and aerodynamic behaviour of glucocorticoid particles prepared by a supercritical fluids process. Eur. J. Pharm. Biopharm. 2004, 21, 501-509.
28. Yeo, S. D.; Lee, J. C. Crystallization of sulfarnethizole using the supercritical and liquid antisolvent processes. J. Supercrit. Fluids 2004, 30, 315-323.
29. Kalogiannis, C. G.; Panayiotou, C. G.; Pavlidou, E. Production of amoxicillin microparticles by supercritical antisolvent precipitation. Ind. Eng. Chem. Res. 2005, 44, 9339-9346.
30. Liu, X.; Li, Z.; Han, B.; Yuan, T. Supercritical antisolvent precipitation of microparticles of quercetin. Chin. J. Chem. Eng. 2005, 13, 128-130.
31. Lobo, J. M.; Schiavone, H.; Palakodaty, S.; Tzannis, S. T.; York, P.; Clark, A. SCF-engineered powders for delivery of budesonide from passive DPI devices. J. Pharm. Sci. 2005, 94, 2276-2288.
32. Su, C.-S.; Chen, Y.-P. Recrystallization of salicylamide using a batch supercritical antisolvent process. Chem. Eng. Technol. 2005, 28, 1177-1181.
33. 2 mixtures. J. Supercrit. Fluids 2005, 35, 95-105.
34. Velaga, S. P.; Carlfors, J. Supercritical fluids processing of recombinant human growth hormone. Drug Dev. Ind. Pharm. 2005, 31, 135-149.
35. Bakhbakhi, Y.; Charpentier, P. A.; Rohani, S. Experimental study of the GAS process for producing microparticles of beclomethasone-17,-21-dipropionate suitable for pulmonary delivery. Int. J. Pharm. 2006, 309, 71-80.
36. Kikic, I.; Alessi, P.; Eva, F.; Moneghini, M.; Perissutti, B. Supercritical antisolvent precipitation of atenolol: The influence of the organic solvent and of the processing approach. J. Supercrit. Fluids 2006, 38, 434-441.
37. Della Porta, G.; Reverchon, E.; De Vittori, C. Supercritical assisted atomization: A novel technology for microparticles preparation of an asthma-controlling drug. AAPS PharmSciTech 2005, 6.
38. Reverchon, E.; Della Porta, G.; Spada, A.; Antonacci, A. Griseofulvin micronization and dissolution rate improvement by supercritical assisted atomization. J. Pharm. Pharmacol. 2004, 56, 1379-1387.
39. Fusaro, F.; Mazzotti, M.; Muhrer, G. Gas antisolvent recrystallization of paracetamol from acetone using compressed carbon dioxide as antisolvent. Cryst. Growth Des. 2004, 4, 881-889.
40. Muhrer, G.; Meier, U.; Fusaro, F.; Albano, S.; Mazzotti, M. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: Generation of drug microparticles and drug-polymer solid dispersions. Int. J. Pharm. 2006, 308, 69-83.
41. Warwick, B.; Dehghani, F.; Foster, N. R.; Biffin, J. R.; Regtop, H. L. Micronization of copper indomethacin using gas antisolvent processes. Ind. Eng. Chem. Res. 2002, 41, 1993-2004.
42. Mammucari, R.; Dehghani, F.; Foster, N. R. Dense gas processing of micron-sized drug formulations incorporating hydroxypropylated and methylated beta-cyclodextrin. Pharm. Res. 2006, 23, 429-437.
43. Hixon, L.; Prior, M.; Prem, H.; Van Cleef, J. Sizing materials by crushing and grinding. Chem. Eng. (New York) 1990, 97, 94-103.
44. Shekunov, B. Y.; York, P. Crystallization processes in pharmaceutical technology and drug delivery design. J. Cryst. Growth 2000, 211, 122-136.
45. York, P. Strategies for particle design using supercritical fluid technologies. Pharm. Sci. Technol. Today 1999, 2, 430-440.
46. Fusaro, F.; Haenchen, M.; Mazzotti, M.; Muhrer, G.; Subramaniam, B. Dense Gas Antisolvent Precipitation: A Comparative Investigation of the GAS and PCA Techniques. Ind. Eng. Chem. Res. 2005, 44, 1502-1509.
47. Wiedmann, T. S. Pharmaceutical Inhalation Aerosol Technology. J. Controlled Release 2005, 105, 177-178.
48. Subra, P.; Jestin, P. Screening design of experiment (DOE) applied to supercritical antisolvent process. Ind. Eng. Chem. Res. 2000, 39, 4178-4184.
49. Box, G. E. P.; Hunter, W. G.; Hunter, J. S. Statistics for Experimenters. An Introduction to Design, Data Analysis and Model Building; J. Wiley and Sons: New York, 1993.
50. Martin, A.; Cocero, M. J. Numerical modeling of jet hydrodynamics, mass transfer, and crystallization kinetics in the supercritical antisolvent (SAS) process. J. Supercrit. Fluids 2004, 32, 203-219.
51. Rajasingam, R.; Lioe, L.; Pham, Q. T.; Lucien, F. P. Solubility of carbon dioxide in dimethylsulfoxide and N-methyl-2-pyrrolidone at elevated pressure. J. Supercrit. Fluids 2004, 31, 227-234.
52. Werling, J. O.; Debenedetti, P. G. Numerical modeling of mass transfer in the supercritical antisolvent process: Miscible conditions. J. Supercrit. Fluids 2000, 18, 11-24.
53. Kerst, A. W.; Judat, B.; Schlunder, E.-U. Flow regimes of free jets and falling films at high ambient pressure. Chem. Eng. Sci. 2000, 55, 4189-4208.
54. Chehroudi, B.; Cohn, R.; Talley, D. Cryogenic shear layers: experiments and phenomenological modeling of the initial growth rate under subcritical and supercritical conditions. Int. J. Heat Fluid Flow 2002, 23, 554-563.
55. Evgenyi Y. Shalaev, G. Z. How does residual water affect the solid-state degradation of drugs in the amorphous state? J. Pharm. Sci. 1996, 85, 1137-1141.